San Francisco - October 19, 2023 - Phizzle, the leader in software used to automate data capture in biopharma applications, today announced a partner agreement with Pedestal Technology to bring Pedestal’s best-in-class, mission-critical technology management to Phizzle’s EDGMaker platform.
“Our GTM strategy is to align with partners who know our market — and how important it is to them to capture siloed data equipment,” said Ben Davis, founder and CEO of Phizzle. “We’re a mission-critical application, and we need partners like Pedestal who have a track record of helping companies at the highest level adopt game-changing technologies like EDGMaker.”
Based in South Carolina, Pedestal has more than 60 combined years of IT enterprise experience. “We are thrilled to announce our strategic partnership with Phizzle,” said Jay McDougall, CEO of Pedestal. “This collaboration brings Pedestal Technology’s capabilities in networking and data to Phizzle, allowing us to deliver even more innovative solutions to our valued clients.”
Phizzle’s EDGMaker is the first production use case of a software-defined architecture to automate data capture in biopharma manufacturing with liquid and air particle counters, pH meters, and balances. EDGMaker automates data capture that is otherwise manually captured, an expensive and error-prone process. This digitization process is also the first step to acquiring consistent, accessible, and high-quality data for AI models.
"By harnessing the power of Phizzle's cutting-edge technology, we aim to redefine the boundaries of data integrity, driving growth, and set new industry standards,” said McDougall. “Together, we believe that we can empower businesses to be more efficient in bringing safer, life-saving drugs like Merck’s Keytruda to market.”
Phizzle’s EDGMaker is the world’s first and only scientific instrument platform to centrally manage drug production data.
Learn more at www.phizzle.com
